The federal health insurance program for people age 65 and older and for other adults who qualify due to having a permanent disability or end-stage renal disease.
During this congressional lunch briefing, analysts will outline the mechanisms of the Medicare Part D program under current law and discuss the potential implications of reforms put forward by Congress and the administration.
During this webinar, analysts discussed the outstanding legislative and regulatory activities that Congress and the administration are likely to pursue before the end of the year.
The audience will come away with a better understanding of the origins of the rebate system, the actors responsible for negotiation, and the impact of rebates on prescription drug prices.
The goal of this briefing was to provide an update on MACRA implementation, the issues on the table as policymakers consider next steps around shifting the way providers are paid, by both public and private payers, and what this all means for improving health outcomes and quality.
This briefing provided an update on the overall state of play with payment reform, and the effort to move away from fee for service and toward value-based payment. Panelists discussed the interplay between the public and private sectors, and, given likely future directions for the CMS Center for Medicare and Medicaid Innovation, highlighted areas where the private sector may be best positioned to lead. Panelists shared what this means for future policy options and needs.
This is the third of three panels from our Care Delivery in the Future: The Role of the Health Care Workforce Summit.
This half-day summit, the third in a series of three, examined many factors that affect the current state of the health care workforce.
Coordinated Care and Beyond: The Future of Integrated Care for Complex Chronic Conditions: What’s Working, What’s Not?
This is the final of three panels from our Future of Chronic Care Summit.
This is the first of three panels from our Future of Chronic Care Summit.
This half-day summit examined how to improve care for patients with complex, chronic conditions.
The Alliance hosted a post-election, half-day symposium previewing critical 2017 health care policy issues, one of the first major gatherings of the health care policy community after the 2016 election.
This briefing featured presentations by our experts highlighting the trends in Medicare regarding prescription drug pricing, and panelists discussed an array of policy options to align drug prices with value through alternative payment models.
Health systems have applied many innovative new strategies for improving quality and reducing costs when it comes to care for high-need, high-cost patients, who typically have multiple chronic conditions. Which of these innovations show promise, and what can we learn from them?
The Centers for Medicare & Medicaid Services (CMS) recently closed the public comment period for its proposed rule to implement the Medicare Access and CHIP Reauthorization Act (MACRA). This means that Medicare will soon change its payment system for physicians, and there could be broad implications for physicians, health systems, health plans, consumers and others.
The Centers for Medicare & Medicaid Services (CMS) closed on June 27 the public comment period for its proposed rule implementing the Medicare Access and CHIP Reauthorization Act (MACRA). This means that Medicare will soon change its payment system to emphasize value over volume, and physicians caring for Medicare patients will need to make decisions about how to adapt their practices to the new incentives.
CMS’s Patrick Conway will meet with reporters May 4th to answer questions about recent developments in ACOs, bundled payments and other Medicare payment demonstrations. He’ll also discuss a recently-announced demo, Comprehensive Primary Care Plus, which could bring more flexibility to 20,000 primary care physicians, and may cover services such as telemedicine.
Medicare is testing new ways to pay for medical services, emphasizing value rather than volume, and evidence is beginning to build about successes and challenges. This briefing will examine what we know so far about the basic models, savings, quality, the impact on patients and the prospects for replication.
With Medicare Advantage (Part C) and prescription drug (Part D) open enrollment beginning October 15th, this briefing took a close look at what to expect, including trends in premiums and cost sharing, plan availability and benefit design.
Per capita spending growth in Medicare has slowed over the last few years, although economists disagree about whether that trend will continue. Meanwhile, the number of Medicare beneficiaries continues to increase. Medicare has made systematic changes over the course of its first 50 years, addressing everything from benefits and eligibility to quality of care measurement and provider payment.
This event examined innovative efforts in both the private and public sectors to move toward a health system that is more patient-centered, cost-efficient and delivers better outcomes. It will address efforts underway at the Center for Medicare and Medicaid Innovation (CMMI) and other federal agencies to spur innovation and prioritize a shift toward higher quality care, as well as the progress made by the private sector in improving quality and reducing costs through innovation.